The clinical process of restoring the appropriate sensitivity and responsiveness of the central and peripheral neuroendocrine pathways that regulate the feeling of fullness and termination of food intake. This recalibration primarily targets the ghrelin-leptin axis and the gut-brain peptide signaling systems, which are often dysregulated in states of chronic energy imbalance or insulin resistance. Effective recalibration is essential for sustainable weight management and metabolic health.
Origin
This concept is rooted in the physiological understanding of appetite regulation, a complex interplay between gut hormones, adipose tissue hormones (leptin), and hypothalamic nuclei. The need for “recalibration” arose from the clinical observation that chronic over-nutrition and inflammation lead to hormone resistance, notably leptin resistance. It defines a therapeutic goal for metabolic syndrome.
Mechanism
Recalibration involves strategies designed to enhance the brain’s sensitivity to circulating satiety hormones, such as Peptide YY (PYY) and Cholecystokinin (CCK), and to reduce the resistance to leptin and insulin. This is often accomplished through dietary modifications that stabilize blood glucose, targeted supplementation, and lifestyle changes that reduce systemic inflammation. The mechanism restores the accurate communication between the gut, fat tissue, and the central nervous system regarding energy status.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.